Details werden geladen...
Do Statins Still Matter in the GLP-1 Era?
Even as GLP-1 drugs transform obesity care and reduce cardiovascular risk, statins retain an essential role in lowering cholesterol and preventing cardiovascular risk events.
Ähnliche Seiten
First-ever clinical guideline issued for cardiovascular-kidney-metabolic (CKM) syndrome | American Heart Association
https://newsroom.heart.org/news/new-guideline-reframes-weight-as-health-risk-tied-to-diabetes-kidney-and-heart-conditions
Metabolic Conditions Common in Chronic Rhinosinusitis
https://www.medscape.com/viewarticle/metabolic-conditions-common-chronic-rhinosinusitis-not-more-2026a1000xho
Viele Patienten mit Essstörungen nehmen GLP-1-Präparate ein
https://www.univadis.de/viewarticle/viele-patienten-essst%C3%B6rungen-nehmen-glp-1-2026a1000m0lIL-6 May Predict HF Risk in Adults With Obesity and Diabetes
https://www.medscape.com/viewarticle/interleukin-6-may-predict-heart-failure-risk-adults-type-2-2026a1000xrsGLP-1 Meds Linked to Symptomatic Remission in UC
https://www.medscape.com/viewarticle/glp-1-meds-linked-symptomatic-remission-ulcerative-colitis-2026a1000wz3